Literature DB >> 18411286

Multiple roles of phospholipase A2 during lung infection and inflammation.

Bryan P Hurley1, Beth A McCormick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18411286      PMCID： PMC2423084          DOI： 10.1128/IAI.00059-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  136 in total

1.  Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells.

Authors:  T Wu; S J Levine; M Cowan; C Logun; C W Angus; J H Shelhamer
Journal:  Am J Physiol       Date:  1997-08

2.  Platelet-activating factor acetylhydrolase inhibits alveolar macrophage activation in vivo.

Authors:  Eileen M Bulger; David Gourlay; Joseph Cuschieri; Sandra Jelacic; Kristen Staudenmeyer; Iris Garcia; Ronald V Maier
Journal:  Shock       Date:  2003-07       Impact factor: 3.454

3.  Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis.

Authors:  L Arbibe; D Vial; I Rosinski-Chupin; N Havet; M Huerre; B B Vargaftig; L Touqui
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

Review 4.  Platelet-activating factor acetylhydrolases.

Authors:  D M Stafforini; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

5.  Differential stimulation of cytosolic phospholipase A2 by bradykinin in human cystic fibrosis cell lines.

Authors:  M Berguerand; E Klapisz; G Thomas; L Humbert; A M Jouniaux; J L Olivier; G Béréziat; J Masliah
Journal:  Am J Respir Cell Mol Biol       Date:  1997-10       Impact factor: 6.914

6.  Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage.

Authors:  M Triggiani; V De Marino; M Sofia; S Faraone; G Ambrosio; L Carratù; G Marone
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

7.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Authors:  L Arbibe; K Koumanov; D Vial; C Rougeot; G Faure; N Havet; S Longacre; B B Vargaftig; G Béréziat; D R Voelker; C Wolf; L Touqui
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

8.  Role of cytosolic phospholipase A2 in allergic response and parturition.

Authors:  N Uozumi; K Kume; T Nagase; N Nakatani; S Ishii; F Tashiro; Y Komagata; K Maki; K Ikuta; Y Ouchi; J Miyazaki; T Shimizu
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

9.  Characterization of a mammalian peroxiredoxin that contains one conserved cysteine.

Authors:  S W Kang; I C Baines; S G Rhee
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

10.  Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2.

Authors:  Sophie Chabot; Kamen Koumanov; Gérard Lambeau; Michael H Gelb; Viviane Balloy; Michel Chignard; Jeffrey A Whitsett; Lhousseine Touqui
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422
View more
  23 in total

1.  Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells.

Authors:  Bryan P Hurley; Waheed Pirzai; Karen L Mumy; Karsten Gronert; Beth A McCormick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

Review 2.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

3.  Cytosolic Phospholipase A2α Promotes Pulmonary Inflammation and Systemic Disease during Streptococcus pneumoniae Infection.

Authors:  Rudra Bhowmick; Stacie Clark; Joseph V Bonventre; John M Leong; Beth A McCormick
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

4.  Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Authors:  Daniele De Luca; Angelo Minucci; Domenico Tripodi; Marco Piastra; Domenico Pietrini; Cecilia Zuppi; Giorgio Conti; Virgilio P Carnielli; Ettore Capoluongo
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

5.  In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Authors:  Carole Guillaume; Christine Payré; Ikram Jemel; Louise Jeammet; Sofiane Bezzine; Gajendra S Naika; James Bollinger; Philippe Grellier; Michael H Gelb; Joseph Schrével; Gérard Lambeau; Christiane Deregnaucourt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

6.  Global metabolomic analysis of a mammalian host infected with Bacillus anthracis.

Authors:  Chinh T Q Nguyen; Vivekananda Shetty; Anthony W Maresso
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

7.  Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain.

Authors:  Yi-Ping Chuang; Zih-Rong Peng; Shun-Fu Tseng; Yu-Chun Lin; Huey-Kang Sytwu; Yu-Chia Hsieh
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

8.  Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.

Authors:  David L Tamang; Waheed Pirzai; Gregory P Priebe; David C Traficante; Gerald B Pier; John R Falck; Christophe Morisseau; Bruce D Hammock; Beth A McCormick; Karsten Gronert; Bryan P Hurley
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

9.  Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.

Authors:  Lael M Yonker; Michael A Pazos; Bernard B Lanter; Hongmei Mou; Kengyeh K Chu; Alexander D Eaton; Joseph V Bonventre; Guillermo J Tearney; Jayaraj Rajagopal; Bryan P Hurley
Journal:  J Immunol       Date:  2017-09-08       Impact factor: 5.422

10.  Low-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.

Authors:  Kelly M Wynalda; Robert C Murphy
Journal:  Chem Res Toxicol       Date:  2010-01       Impact factor: 3.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.